← Back to Search

Behavioural Intervention

Neuromodulation + Cognitive Training for Traumatic Brain Injury (CONNECT-TBI Trial)

N/A
Recruiting
Led By Davin k Quinn, MD, FACLP
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Experienced less than 24 hours of post-traumatic amnesia (PTA)
Veterans and Warfighters aged 18-59
Must not have
Recent medical hospitalization (within three weeks)
Prior history of other neurological disease or any history of seizures beyond immediate post-traumatic seizure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment visit and long-term follow-up at 3 and 6 months

Summary

This trial is testing if a certain combination of treatments can help improve cognitive functioning for people with complex mTBI and PPCS.

Who is the study for?
This trial is for Veterans aged 18-59 who've had a mild traumatic brain injury (TBI) with specific cognitive symptoms, and have been stable on any psychotropic meds for 2 months. They must not be pregnant, involved in TBI litigation, or have certain medical conditions like psychosis or recent substance dependence.
What is being tested?
The CONNECT-TBI Trial tests whether Attention Process Training combined with either rTMS (magnetic stimulation), HD-tDCS (electrical brain stimulation), or sham treatment improves cognitive function in those with complex mTBI. Participants will undergo extensive testing before and after the treatments to measure effectiveness.
What are the potential side effects?
Potential side effects from rTMS may include headaches, scalp discomfort at the site of stimulation, lightheadedness, and rare risk of seizure. HD-tDCS might cause skin irritation under the electrodes used for stimulation as well as tingling sensations during application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had memory loss for less than a day after my injury.
Select...
I am a veteran or warfighter between 18 and 59 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was hospitalized within the last three weeks.
Select...
I have a history of neurological diseases or seizures not caused by immediate trauma.
Select...
I do not have severe hearing loss or blindness that would prevent me from completing cognitive training.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-treatment visit and long-term follow-up at 3 and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment visit and long-term follow-up at 3 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary cognitive outcome: Change from baseline in objective cognitive control as measured by accuracy on the Multi-modal Working Memory N-back task (MMWM) to post-treatment Visit.
Primary functional outcome: Change from post-treatment visit in overall quality of life as measured by the PGIC at long-term follow-up at 3 and 6 months.
Primary imaging outcome: Change (decrease) in CCN activity from Baseline Visit to Post-treatment Visit as measured by the BOLD signal during the MMWM task performance.
+1 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Active rTMS with Attention Process TrainingActive Control2 Interventions
Subjects in this arm will receive active rTMS and then complete the assigned Attention Process Training battery immediately following active rTMS.
Group II: Active HD-tDCS with Attention Process TrainingActive Control2 Interventions
Subjects in this arm will receive active HD-tDCS and complete the assigned Attention Process Training battery during active HD-tDCS.
Group III: Sham rTMS with Attention Process TrainingPlacebo Group2 Interventions
Subjects in this sham arm will not receive any active stimulation and will only complete Attention Process Training immediately following sham rTMS.
Group IV: Sham HD-tDCS with Attention Process TrainingPlacebo Group2 Interventions
Subjects in this sham arm will not receive any active stimulation and will only complete Attention Process Training during sham HD-tDCS.

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
388 Previous Clinical Trials
3,526,495 Total Patients Enrolled
The Mind Research NetworkOTHER
26 Previous Clinical Trials
2,234 Total Patients Enrolled
New Mexico VA Healthcare SystemFED
8 Previous Clinical Trials
957 Total Patients Enrolled
Minneapolis Veterans Affairs Medical CenterFED
76 Previous Clinical Trials
354,677 Total Patients Enrolled
University of MinnesotaOTHER
1,439 Previous Clinical Trials
1,621,850 Total Patients Enrolled
New Mexico Veterans Affairs Health Care SystemUNKNOWN
The United States Department of Defense USAMRDCUNKNOWN
Davin k Quinn, MD, FACLPPrincipal InvestigatorUniversity of New Mexico

Media Library

Attention Process Training (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05236010 — N/A
Traumatic Brain Injury Research Study Groups: Active rTMS with Attention Process Training, Sham rTMS with Attention Process Training, Active HD-tDCS with Attention Process Training, Sham HD-tDCS with Attention Process Training
Traumatic Brain Injury Clinical Trial 2023: Attention Process Training Highlights & Side Effects. Trial Name: NCT05236010 — N/A
Attention Process Training (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05236010 — N/A
~22 spots leftby Oct 2025